Tropisetron

Tropisetron

Clinical data
Pregnancy category	AU: X (High risk)
Routes of administration	Oral, IM
ATC code	A04AA03 (WHO)
Legal status
Legal status	AU: S4 (Prescription only) UK: POM (Prescription only)
Pharmacokinetic data
Bioavailability	~60–80%
Protein binding	71%
Metabolism	Hepatic (CYP3A4, CYP1A2, CYP2D6)
Elimination half-life	6–8 hours
Excretion	Renal, Fecal
Identifiers
IUPAC name [(1S,5S)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] 1H-indole-3-carboxylate
CAS Number	89565-68-4
PubChem CID	72165
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C17H20N2O2
Molar mass	284.353 g/mol
3D model (JSmol)	Interactive image
SMILES CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43

WikiDoc Resources for Tropisetron
Articles
Most recent articles on Tropisetron Most cited articles on Tropisetron Review articles on Tropisetron Articles on Tropisetron in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Tropisetron Images of Tropisetron Photos of Tropisetron Podcasts & MP3s on Tropisetron Videos on Tropisetron
Evidence Based Medicine
Cochrane Collaboration on Tropisetron Bandolier on Tropisetron TRIP on Tropisetron
Clinical Trials
Ongoing Trials on Tropisetron at Clinical Trials.gov Trial results on Tropisetron Clinical Trials on Tropisetron at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Tropisetron NICE Guidance on Tropisetron NHS PRODIGY Guidance FDA on Tropisetron CDC on Tropisetron
Books
Books on Tropisetron
News
Tropisetron in the news Be alerted to news on Tropisetron News trends on Tropisetron
Commentary
Blogs on Tropisetron
Definitions
Definitions of Tropisetron
Patient Resources / Community
Patient resources on Tropisetron Discussion groups on Tropisetron Patient Handouts on Tropisetron Directions to Hospitals Treating Tropisetron Risk calculators and risk factors for Tropisetron
Healthcare Provider Resources
Symptoms of Tropisetron Causes & Risk Factors for Tropisetron Diagnostic studies for Tropisetron Treatment of Tropisetron
Continuing Medical Education (CME)
CME Programs on Tropisetron
International
Tropisetron en Espanol Tropisetron en Francais
Business
Tropisetron in the Marketplace Patents on Tropisetron
Experimental / Informatics
List of terms related to Tropisetron

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Tropisetron (INN) is a serotonin 5-HT₃ receptor antagonist used mainly to treat nausea and vomiting following chemotherapy, although it has been used experimentally as an analgesic in cases of fibromyalgia. The drug is available in a 5 mg oral preparation or in 2 mg intravenous form. It is marketed by Novartis in Europe, Australia and New Zealand as Navoban, but is not available in the U.S.

Adverse effects

Tropisetron is a well-tolerated drug with few side effects. Headache, constipation, and dizziness are the most commonly reported side effects associated with its use. There have been no significant drug interactions reported with this drug's use. It is broken down by the hepatic cytochrome P450 system and it has little effect on the metabolism of other drugs broken down by this system.

External links

• - Official site
• Navoban data sheet